Low-toxic myeloablative conditioning regimen in haploidentical hematopietic stem cell transplantation for elderly patients with acute myeloid leukemia.

被引：0
|
作者：
Aristei, Cynthia
Lancellotta, Valentina
Carotti, Alessandra
Zucchetti, Claudio
Pierini, Antonio
Saldi, Simonetta
Ruggeri, Loredana
Amico, Lucia
Iacco, Martina
Velardi, Andrea
Martelli, Massimo Fabrizio
机构：
[1] Univ Perugia, Radiat Oncol Sect, Dept Surg & Biomed Sci, Perugia, Italy
[2] Perugia Gen Hosp, Perugia, Italy
[3] Perugia Gen Hosp, Div Hematol & Clin Immunol, Perugia, Italy
[4] Perugia Gen Hosp, Dept Med, Bone Marrow Transplant Program, Perugia, Italy
[5] Univ Perugia, Perugia, Italy
[6] Santa Maria della Misericordia Hosp, Dept Med Phys, Med Phys Unit, Perugia, Italy
[7] Univ Perugia, Radiat Oncol Sect, Perugia, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.7038
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7038
引用
收藏
页数：1
相关论文
共 50 条
  • [1] TMLI-based low-toxic myeloablative conditioning regimen in haploidentical HSCT for AML
    Aristei, C.
    Lancellotta, V.
    Carotti, A.
    Zucchetti, C.
    Saldi, S.
    Pierini, A.
    Ruggeri, L.
    Piccinini, S.
    Amico, L.
    Iacco, M.
    Velardi, A.
    Martelli, M. F.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S182 - S183
  • [2] Non-myeloablative conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia. The impact of the remission status
    Gutierrez-Aguirre, CH
    Cantu-Rodriguez, OG
    Gonzalez-LLano, O
    Salazar-Riojas, R
    Martinez-Gonzalez, OL
    Jaime-Perez, JC
    Gomez-Almaguer, D
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 61 - 62
  • [3] Flat Regimen as Myeloablative Conditioning with Limited Toxicities for Autologous Stem Cell Transplantation in Patients with Acute Myeloid Leukemia: Results in 30 Patients
    Bernardi, Massimo
    Messina, Carlo
    Mastaglio, Sara
    Lorentino, Francesca
    Pavesi, Francesca
    Carrabba, Matteo Giovanni
    Peccatori, Jacopo
    Assanelli, Andrea
    Vago, Luca
    Gentner, Bernhard
    Milani, Raffaella
    Ronchi, Paola
    Giglio, Fabio
    Liberatore, Carmine
    Erbella, Federico
    Clerici, Daniela
    Ciceri, Fabio
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 200 - 201
  • [4] Decitabine as a conditioning regimen in haploidentical stem cell transplantation for refractory acute myeloid leukaemia
    Zhang, C.
    Chen, X. -H.
    Liu, J.
    Gao, L.
    Liu, Y.
    Gao, L.
    Kong, P. -Y.
    Zhang, X.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2015, 40 (03) : 336 - 338
  • [5] INTRAVENOUS BUSULFAN IN AUTOLOGOUS STEM CELL TRANSPLANTATION CONDITIONING REGIMEN FOR ADULT PATIENTS WITH ACUTE MYELOID LEUKEMIA. MULTICENTRE RETROSPECTIVE ANALYSIS
    Grande, C.
    Garcia Sanchez, P. J.
    de la Rubia, J.
    Serrano, D.
    Lopez Duarte, M.
    Garcia Boyero, R.
    Rosique, P.
    Heras, I.
    Martinez, R.
    Lahuerta, J. J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 292 - 293
  • [6] Feasibility of autologous peripheral blood stem cell transplantation in elderly patients with acute myeloid leukemia.
    Ferrara, F
    Palmieri, S
    Celentano, M
    Desimone, M
    Mele, G
    Annunziata, M
    BLOOD, 2005, 106 (11) : 461B - 461B
  • [7] Comparison of myeloablative vs reduced intensity conditioning regimens in stem cell transplantations for acute myeloid leukemia.
    Gurman, Gunhan
    Guloksuz, Gozde Aydemir
    Atilla, Erden
    Atilla, Pinar Ataca
    Bozdag, Sinem Civriz
    Yuksel, Meltem Kurt
    Toprak, Selami Kocak
    Topcuoglu, Pervin
    Ozcan, Muhit
    Arslan, Onder
    Demirer, Taner
    Akan, Hamdi
    Ilhan, Osman
    Beksac, Meral
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [8] Reduced Intensity Versus Myeloablative Conditioning for Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia
    Fan, Donna
    Sabry, Waleed
    Stakiw, Julie
    MacKay, Rebecca Ellyn
    Bosch, Mark
    Sarker, Sabuj
    Elemary, Mohamed
    BLOOD, 2014, 124 (21)
  • [9] Non-myeloablative allogeneic stem cell transplantation for the treatment of patients with chronic myeloid leukemia.
    Slavin, S
    Nagler, A
    Shapira, M
    Aker, M
    Or, R
    BLOOD, 2000, 96 (11) : 203A - 203A
  • [10] Non-myeloablative conditioning regimen in patients with high risk acute myeloid leukemia:: unrelated and sibling allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
    Basara, N
    Roemer, E
    Günzelmann, S
    Schmetzer, B
    Fauser, AA
    Kiehl, MG
    BONE MARROW TRANSPLANTATION, 2001, 27 : S86 - S86
12345